s.dziedzic

TL2 · Hyderabad

Contributes reviews on supplier material. Based in Hyderabad.

Joined 17 August 2025 · last posted 6h

87 posts, newest first. Showing up to 150.

Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #3 · Compounds › Oral incretins · 28 Jul 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Orforglipron is a small molecule, not a peptide. That changes almost everything:…
Journal club: what we got wrong in an earlier session Replied, post #124 · Evidence › Journal club · 26 Jul 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
What is genuinely unknown about long-term amylin agonism Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
Reading a home test result without over-claiming Replied, post #125 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Second pass at: Reading a trial's population section before its results Replied, post #4 · Evidence › Trials · 18 Jul 2026 · 0 likes The opening post answers the question as asked. The question underneath it is different. Composite endpoints should be read component by component. A composite driven…
Revisiting: The best-written scientific paper you have read Replied, post #96 · Lounge › Off topic · 16 Jul 2026 · 5 likes Summarising the best-written scientific paper thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #53 · Practice › Side effects · 16 Jul 2026 · 2 likes Post #49 and I disagree about the size of the effect, not about the direction. The relationship between symptom burden and outcome is not what people assume. Feeling…
A structured critique template this community uses — a second dataset Replied, post #34 · Evidence › Study critique · 10 Jul 2026 · 11 likes Structured critique template came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Pooling trials with different estimands Replied, post #84 · Evidence › Meta-analyses · 9 Jul 2026 · 0 likes Pooling trials with different estimands looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in…
Insurance and replacement policies, compared Replied, post #55 · Sourcing › Logistics · 1 Jul 2026 · 33 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. That matches what I was told, which is not the same as…
Designing a personal experiment that could change your mind — one year on Replied, post #65 · Research Methods › N-of-1 designs · 24 Jun 2026 · 1 like Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have found that a prescriber will happily discuss a…
Coming back to: Time to steady state after a dose increase Replied, post #78 · Pharmacology › Pharmacokinetics · 16 Jun 2026 · 7 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #88 · Evidence › Journal club · 16 Jun 2026 · 3 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Does dual agonism explain the effect size, or is it dose? Replied, post #39 · Compounds › Tirzepatide · 16 Jun 2026 · 22 likes Post #36 is the version of this I will quote in future. One addition. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were…
Micronutrient adequacy at low total intake Replied, post #55 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 0 likes The most useful thing anyone has posted about micronutrient adequacy in this category was a table of what had been measured and by whom. That is what I would want again.
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #54 · Analytics › HPLC & UHPLC · 7 Jun 2026 · 13 likes Post #52 is right about the mechanism and I think understates the practical bit. I would be cautious about generalising from the Area percent versus weight percent…
Prescription portability between countries Replied, post #50 · Access › International · 1 Jun 2026 · 2 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. Reading it again,…
Revisiting: What pooling buys you and what it destroys Replied, post #37 · Evidence › Meta-analyses · 29 May 2026 · 18 likes Answering the question post #33 raises rather than the one it answers. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
Talking to a therapist about this specifically Replied, post #8 · Wellbeing › Mental health · 27 May 2026 · 5 likes Worth separating two things that post #6 runs together. Nothing here is medical advice and several members in this subcategory say plainly that they are describing…
Validating a calculator against hand arithmetic Replied, post #22 · Data & Tools › Calculators · 2 May 2026 · 7 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Why calculators are not medical advice: they do arithmetic. Medical decisions are…
List price versus negotiated price versus what you pay Replied, post #49 · Access › Pricing · 12 Apr 2026 · 32 likes Understood, and I withdraw the assumption I opened with.
Spike-and-recover accuracy for a peptide assay Replied, post #40 · Analytics › Method validation · 8 Apr 2026 · 14 likes For anyone finding this later: the short answer on spike-and-recover accuracy is that it depends on one thing, and the rest of the thread is people identifying which…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #8 · Pharmacology › Pharmacokinetics · 7 Apr 2026 · 18 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none. I checked the…
A plateau that disappeared when I changed how I measured Replied, post #29 · Outcomes › Progress reports · 3 Apr 2026 · 4 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #130 · Access › Pricing · 29 Mar 2026 · 5 likes I disagree with the framing of Price changes above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Second pass at: Identical chromatograms across two different lots Replied, post #93 · Sourcing › Red flags · 25 Mar 2026 · 31 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker statement.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #69 · Compounds › Repair & healing peptides · 15 Mar 2026 · 0 likes Where I part company with post #67, and it is a narrow parting. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal —…
Preservatives: function, testing, and limits — one year on Started this topic · Pharmacology › Formulation chemistry · 16 Feb 2026 · 18 likes On the subject in the title: Preservatives: function, testing, and limits — one year on Working notes rather than a conclusion. Asking about Preservatives directly,…
Research-use-only labelling: what it means and what it does not Replied, post #95 · Sourcing › Regulatory · 30 Jan 2026 · 14 likes I had written a reply contradicting post #93 and deleted it. Here is what survived. Nobody has said the unglamorous part of research-use-only labelling yet, so: most of…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #109 · Clinical › Special populations · 26 Jan 2026 · 18 likes Narrowing post #108, because the general version has more than one answer. Post-surgical populations, particularly after procedures affecting the gastrointestinal…
Reconstitution volumes that produce round numbers, tabulated Replied, post #33 · Practice › Reconstitution · 26 Jan 2026 · 26 likes Adding the measurement that post #30 says would settle it. The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume,…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #80 · Wellbeing › Mental health · 22 Jan 2026 · 27 likes Answering the Anxiety question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #20 · Clinical › Special populations · 21 Jan 2026 · 11 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Request: a diff view for wiki revisions — the long version Replied, post #98 · Meta › Feature requests · 12 Jan 2026 · 0 likes The caveat is the whole objection, I think. A comparison view makes two numbers look commensurable when the records behind them are different sizes.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #23 · Regional › UK & Ireland · 30 Dec 2025 · 1 like I read post #21 twice before replying, because I had assumed the opposite. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and…
Availability by country, dated, with primary sources — one year on Replied, post #3 · Access › International · 29 Nov 2025 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
Micro-titration: a disputed topic, argued properly Replied, post #7 · Practice › Dosing & titration · 29 Nov 2025 · 18 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #87 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Building on post #86 rather than restating it. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result…
[2026 update] Comparing prices across jurisdictions without misleading yourself Started this topic · Access › Pricing · 18 Nov 2025 · 38 likes On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Comparing prices across…
The headache that turns out to be dehydration Replied, post #51 · Nutrition & Training › Hydration & electrolytes · 9 Nov 2025 · 8 likes That is a cleaner way of putting what I was circling around.
Lyophilisation and why the cake looks the way it does Replied, post #22 · Pharmacology › Formulation chemistry · 27 Oct 2025 · 0 likes Osmolality of a home-reconstituted preparation is whatever the diluent makes it, and nobody is measuring it. In practice at these volumes it is a comfort question.
New subcategory: rationale and scope Replied, post #124 · Meta › Announcements · 26 Oct 2025 · 0 likes Post #121 is right about the mechanism and I think understates the practical bit. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS…
Run-in periods and the population they select Replied, post #14 · Evidence › Trials · 25 Oct 2025 · 9 likes Post #12 answers the question as asked. The question underneath it is different. For anyone finding this later: the short answer on run-in periods is that it depends on…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #96 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 14 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
How to ask about something you suspect is a bad idea Replied, post #13 · Start Here › How to Ask · 2 Oct 2025 · 15 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. A photograph of a vial is rarely useful and a photograph of a document usually is.…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #88 · Evidence › Preprints · 2 Oct 2025 · 16 likes Citing a preprint: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #33 · Compounds › Tirzepatide · 1 Oct 2025 · 11 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
Managing an unplanned gap in supply — what changed since Replied, post #69 · Access › Shortages · 23 Sep 2025 · 0 likes Taking post #68 at face value and following it one step further. International supply chains: a shortage in one country does not mean shortage in another. That is why…
Second pass at: Programming during a large energy deficit Replied, post #14 · Nutrition & Training › Resistance training · 21 Sep 2025 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
Documentation that materially improves an appeal's chances Replied, post #4 · Access › Insurance & coverage · 17 Sep 2025 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Practical note on documentation: write down what you expect before…
Washout: how long is long enough, and for what purpose Replied, post #66 · Pharmacology › Pharmacokinetics · 13 Sep 2025 · 23 likes The bit of washout that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
Substitution between formats during a shortage Replied, post #48 · Access › Shortages · 31 Aug 2025 · 16 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #30 · Start Here › Welcome · 24 Aug 2025 · 18 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
What this community means by "a source", in practical terms Replied, post #79 · Start Here › Welcome · 20 Aug 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Why "any advice?" is the least effective ending for a post — the long version Replied, post #41 · Start Here › How to Ask · 20 Aug 2025 · 0 likes Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can change them later. I would put the burden of proof on the…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #11 · Clinical › Special populations · 18 Aug 2025 · 24 likes Post #8 answers the question as asked. The question underneath it is different. Older adults were included in the trials in smaller numbers than their share of the…
Temperature loggers worth the money — the long version Replied, post #22 · Devices › Cold chain · 8 Aug 2025 · 0 likes Practical answer on Temperature loggers worth the money, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
Revisiting: List price versus negotiated price versus what you pay Replied, post #13 · Access › Pricing · 6 Aug 2025 · 22 likes One caution on List price versus negotiated price: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and…
What a documentation review can and cannot tell you Replied, post #60 · Sourcing › Independent verification · 4 Aug 2025 · 14 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #5 · Practice › Side effects · 25 Jul 2025 · 15 likes Agreed on Fatigue, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
Titles that describe the question, not the situation Replied, post #46 · Start Here › How to Ask · 11 Jul 2025 · 7 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Needle changes between doses on a reusable pen Replied, post #19 · Devices › Pens & autoinjectors · 7 Jul 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #9 · Compounds › Semaglutide · 28 Jun 2025 · 0 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Anxiety in the first weeks: drug, situation, or both Replied, post #105 · Wellbeing › Mental health · 20 Jun 2025 · 22 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase. The interesting part of this is the…
[2026 update] An appeal that failed, and what I would do differently Replied, post #126 · Access › Insurance & coverage · 15 Jun 2025 · 1 like This follows post #123 rather than contradicting it. The strongest argument against my own position on appeal, stated as well as I can state it, since nobody else has…
Price changes over 2025 and 2026, tabulated and dated Replied, post #8 · Access › Pricing · 10 Jun 2025 · 0 likes Where a price is quoted per vial, the fill has to be stated for the comparison to mean anything. It is worth checking rather than assuming, which costs nothing.
DXA precision and the least significant change for lean mass — the long version Replied, post #89 · Outcomes › Body composition · 24 May 2025 · 13 likes Post #87 is the version of this I will quote in future. One addition. Adding the boring version of DXA precision, because the interesting version keeps getting posted…
Washout: how long is long enough, and for what purpose Replied, post #26 · Pharmacology › Pharmacokinetics · 14 May 2025 · 3 likes This follows post #23 rather than contradicting it. Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling…
A claim built entirely on a subgroup analysis Replied, post #7 · Evidence › Study critique · 26 Apr 2025 · 0 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. Flagging…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #48 · Evidence › Journal club · 22 Mar 2025 · 5 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #14 · Access › Pricing · 20 Mar 2025 · 12 likes Building on post #13 rather than restating it. Whatever the answer on cheapest option turns out to be, the method for getting there is the same: state the assumption,…
Adjudicated events and why the definition matters — the long version Replied, post #54 · Evidence › Trials · 19 Mar 2025 · 15 likes Offering a way to settle Adjudicated events rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
About the Journal club category Replied, post #6 · Evidence › Journal club · 10 Mar 2025 · 10 likes I read post #2 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
Telehealth prescribing models in the US Replied, post #67 · Regional › North America · 7 Mar 2025 · 5 likes I read post #64 twice before replying, because I had assumed the opposite. The useful distinction on telehealth prescribing models is between what was measured and what…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #50 · Access › International · 17 Feb 2025 · 31 likes Before the thread moves on from Cross-border purchase within — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #58 · Compounds › Secretagogues & GH axis · 30 Jan 2025 · 0 likes Adding a reference point for well-designed human trial. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Fixed versus detachable needles: the trade-offs Replied, post #85 · Devices › Syringes & needles · 1 Jan 2025 · 10 likes This follows post #83 rather than contradicting it. Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short needles…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #51 · Compounds › Other compounds · 29 Dec 2024 · 29 likes Research-use-only status sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #3 · Access › Pricing · 11 Dec 2024 · 30 likes I came in to disagree and I am leaving without a disagreement.
Promotion criteria, and the one that stops most nominations Replied, post #136 · Documentation › Doc review · 9 Dec 2024 · 25 likes Picking up post #133: that is the part I would want checked first. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #26 · Compounds › Secretagogues & GH axis · 2 Dec 2024 · 0 likes Counterpoint on pulsatile secretion, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Second pass at: Choosing a concentration on purpose rather than by accident Started this topic · Practice › Reconstitution · 28 Oct 2024 · 0 likes Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. Posting a…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #112 · Clinical › Comorbidities · 27 Oct 2024 · 4 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
When a preprint is the best available evidence and we say so — a second dataset Replied, post #3 · marked as the solution · Evidence › Preprints · 7 Oct 2024 · 7 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it. Not…
Air bubbles in a subcutaneous injection: the honest risk assessment Replied, post #4 · Practice › Administration · 17 Sep 2024 · 2 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
Converting between mg/mL and units per dose, both directions Replied, post #18 · Practice › Reconstitution · 13 Sep 2024 · 2 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Reporting a discrepancy without making an allegation Replied, post #39 · Sourcing › Vendor reports · 23 Aug 2024 · 32 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That has held every time I have looked, which is not…